Effective and safe but forgotten: Methsuximide in intractable epilepsies in childhood

Seizure

Volumn 10, Issue 2, 2001, Pages 120-124

  Sigler, Matthias ^a,b   Strassburg, Hans Michael ^c   Boenigk, Hans Erich ^a  

^a EPILEPSY CENTER BETHEL   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Intractable childhood epilepsy; Lennox Gastaut syndrome; Metabilism of methsuximide; Methsuximide; N desmethylmethsuximide; Symptomatic focal epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; MESUXIMIDE; NORMESUXIMIDE;

ADOLESCENT; ADULT; AGGRESSION; ARTICLE; ATAXIA; CHILD; CHILDHOOD; CLINICAL OBSERVATION; CLINICAL PROTOCOL; CLINICAL TRIAL; DROWSINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; FEMALE; HICCUP; HOSPITAL PATIENT; HUMAN; INFANT; INTRACTABLE EPILEPSY; LEUKOPENIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; REFRACTORY PERIOD; SIDE EFFECT; TITRIMETRY; VOMITING;

EID: 0035010804     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1053/seiz.2000.0467     Document Type: Article

References (28)

1. Chen G., Portman R., Ensor C. R., Bratton A. C. The anticonvulsant activity of a-phenyl succinimides. Journal of Pharmacology and Experimental Therapeutics. 103:1951;54-61.
2. Miller C. A., Long L. M. Anticonvulsants. I. An investigation of N-R-a-R1-a-phenylsuccimides. Journal of the American Chemical Society. 73:1951;4895-4898.
3. Miller C. A., Scholl H. I., Long L. M. Anticonvulsants. II. A study of N-R-a, b-substituted succimides. Journal of the American Chemical Society. 73:1951;5608-5610.
4. Zimmerman F. T. Use of methylphenylsuccimide in treatment if petit mal epilepsy. Archives of Neurology and Psychiatry. 66:1951;156-162.
5. Strong J. M., Abe T., Gibbs E. L., Atkinson J. Plasma levels of methsuximide and N-desmethylmethsuximide during methsuximide therapy. Neurology. 24:1974;250-255.
6. Browne T. R. Other succinimides - Methsuximide. Levy R., Meldrum B., Mattson R., Penry J. K., Dreifuss F. E. Antiepileptic Drugs. 1999;707-714 Raven Press, New York.
7. Rambeck B. Pharmacological interactions of mesuximide with phenobarbital and phenytoin in hospitalized epileptic patients. Epilepsia. 20:1979;147-156.
8. Browne T. R., Feldman R. G., Buchanan R. A. et al. Methsuximide for complex partial seizures: efficacy, toxicity, clinical pharmacology, and drug interactions. Neurology. 33:1983;414-418.
9. Livingston S., Pauli L. Celontin (PM-396) in the treatment of epilepsy. Pediatrics. 19:1956;614-618.
10. Cordoba E. F., Strobos R. R. J. N-Methyl-a, a-Methyl- phenylsuccinimide in psychomotor epilepsy. Diseases of the Nervous System. 17:1956;383-385.
11. Stenzel E., Boenigk H. E., Rambeck B. [Methsuximide in the treatment of epilepsies]. Nervenarzt. 48:1977;377-382.
12. Hurst D. L. Methsuximide therapy of juvenile myoclonic epilepsy. Seizure. 5:1996;47-50.
13. Karch S. B. Methsuximide overdose. Delayed onset of profound coma. Journal of the American Medical Association. 223:1973;1463-1465.
14. Tennison M. B., Greenwood R. S., Miles M. V. Methsuximide for intractable childhood seizures. Pediatrics. 87:1991;186-189.
15. Pellock J. M., Appleton R. Use of new antiepileptic drugs in the treatment of childhood epilepsy. Epilepsia. 40 (Suppl. 6):1999;S29-S38.
16. Gastaut H., Roger J., Soulayrol R. et al. Epileptic encephalopathy of children with diffuse slow spikes and waves (alias 'petit mal variant') or Lennox syndrome. Annals of Pediatrics Paris. 13:1966;489-499.
17. Juergens U. Simultaneous determination of Zonisamide and nine other anti-epileptic drugs and metabolites in serum. A comparison of microbore and conventional high-performance liquid chromatography. Journal of Chromatography. 385:1987;233-240.
18. Wilder B. J., Buchanan R. A. Methsuximide for refractory complex partial seizures. Neurology. 31:1981;741-744.
19. Dreyer R. Preliminary experience with the succinimide 'Celontin' in epilepsy therapy. Die Medizinische. 16:1959;801-804.
20. Zimmerman F. T., Burgermeister B. B. Use of N-Methyl-a, a-Methylphenylsuccinimide in treatment of petit mal epilepsy. Archives of Neurology and Psychiatry. 72:1954;720-725.
21. Zimmerman F. T. N-Methyl-a, a-Methylsuccinimide in psychomotor epilepsy therapy. Archives of Neurology and Psychiatry. 76:1956;65-71.
22. Carter C. H., Maley M. C. Use of Celontin in the treatment of mixed epilepsies. Neurology. 7:1957;483-484.
23. Dow R. S., Macfarlane J. P., Stevens J. R. Celontin in patients with refractory epilepsy. Neurology. 8:1958;201-204.
24. French E. G., Rey-Bellet J., Lennox W. G. Methsuximide in psychomotor and petit-mal seizures. New England Journal of Medicine. 258:1958;892-894.
25. Scholl C. J.A., Abbott J. A., Schwab R. S. Celontin - a new anticonvulsant. Epilepsia. 1:1959;109.
26. Trolle E., Kiorboe E. Treatment of petit mal epilepsy with new succinimides: PM 680 and Celontin. Epilepsia. 1:1959;587-591.
27. Rabe F. Celontin (Petinutin) - contribution to a differentiated epilepsy therapy. Nervenarzt. 31:1960;306-312.
28. Browne T. R., Feldman R. G., Norman S. E., Fawcett-Vickers L., Szabo G. K. Methsuximide (Celontin) for complex partial seizures: Efficacy, toxicity, clinical pharmacology, and drug interactions. Neurology. 30:1980;355.